HYPD Stock Analysis

Hyperion DeFi, Inc.
HEALTHCARE BIOTECHNOLOGY

Back to Winners View Yahoo Finance Chart Buy on the Dip
Strong Caution Mixed Weak Unavailable
StockValueFinder Grade
F
30.41 / 100
Weak
Confidence: High (80.0%) Coverage: 80.0%
Business Quality 19.5
Financial Strength 43.0
Earnings & Growth 50.5
Valuation 27.5
Market Strength 9.0
The grade combines Business Quality, Financial Strength, Earnings & Growth, Valuation, and Market Strength. Rating and Trend remain separate signals.
Rating AVOID
Avoid
The screening rules are warning against this setup.
Rating is the simple decision label from the screening rules.
Trend WEAK TREND
Unclear
Trend interpretation is unavailable.
Trend shows whether price action is helping or hurting the setup.
P/E Ratio -0.28
Not Meaningful
Negative or missing earnings make P/E hard to use.
P/E shows how much investors pay for each dollar of earnings.
ROIC -91.41%
Poor
Negative ROIC suggests capital is not being used profitably.
ROIC measures how efficiently capital turns into profit.
Debt Payback -0.53 yrs
Unavailable
Debt payback is unavailable or not meaningful.
Debt payback estimates how quickly debt could be covered.
Interest Coverage -12.18x
Poor
Negative coverage means earnings are not covering interest costs.
Interest coverage shows how easily earnings cover interest costs.
Price $2.92
Market Price
Price alone is not a buy or sell signal.
Price should be judged with valuation, quality, and trend.
Last updated: 2026-10-23 15:48:39

Performance Overview

Trailing adjusted-close returns as of 2026-07-10. Benchmark is SPY.

YTD Return

HYPD -13.20%
SPY +11.30%

1-Year Return

HYPD -75.46%
SPY +21.97%

3-Year Return

HYPD -98.48%
SPY +78.24%

5-Year Return

HYPD -99.18%
SPY +85.50%

Returns are calculated from adjusted close prices and may differ from broker or research-site totals depending on data source, dividend handling, benchmark choice, and latest available trading date.

Legacy Screening Checks

This page uses cached SQL data from the latest StockValueFinder scan, so it loads fast without hitting Alpha Vantage on every page view.

40%
EPS Strength
FAIL

Looks for positive and improving earnings per share.

ROIC 10%+
FAIL

Looks for strong return on invested capital.

Interest Coverage 6+
FAIL

Checks whether operating income comfortably covers interest expense.

Debt Payback ≤ 3 Years
PASS

Checks whether free cash flow could pay down long-term debt quickly.

P/E 15 or Less
PASS

Checks whether valuation is reasonable under the current rule set.

Moving Average Trend
WEAK TREND

Uses 20-day, 50-day, and 200-day moving averages for entry timing context.

A high StockValueFinder score is a research signal, not a guarantee. Strong companies can still fall during recessions, sector downturns, valuation resets, or company-specific events. Always review the business, risks, SEC filings, valuation, and your personal investment goals before buying.

Cached Technical Data

Moving average values from the latest stored scan.

20-Day MA3.45
50-Day MA3.41
200-Day MA3.37
MA Score2

Latest Published Stock Research

Research generated: October 23, 2026

HYPD Stock Analysis: Why Hyperion DeFi, Inc. Scored 40% in Stock Value Finder

Hyperion DeFi, Inc.: An Educational StockValueFinder Review

Hyperion DeFi, Inc. (HYPD) is a biotechnology company operating within the healthcare sector. This article will provide an in-depth review of HYPD based on the metrics and data available through StockValueFinder.com, focusing on financial health, valuation, and market trends.

Why the StockValueFinder Score Matters

StockValueFinder evaluates stocks across various financial metrics to determine their overall strength and potential risks. For Hyperion DeFi, Inc., the stock has received a score of 40% with an AVOID rating. This rating suggests that based on the current data, HYPD may not be a suitable investment at this time due to several concerning financial indicators.

EPS Strength and Consistency

Earnings per share (EPS) is a critical metric for evaluating a company's profitability. High and consistent EPS values indicate strong earnings performance over time. For Hyperion DeFi, Inc., the system recorded that HYPD did not pass the EPS test. This result suggests that the company may be experiencing inconsistent or declining earnings, which can be a red flag for investors.

**Example:** A company with stable EPS growth of 5% year-over-year is generally more attractive than one showing erratic fluctuations or negative trends in its EPS numbers.

ROIC and Capital Efficiency

Return on Invested Capital (ROIC) measures how effectively a company uses capital to generate profits. StockValueFinder prefers companies with an ROIC of at least 10%. Hyperion DeFi, Inc.'s ROIC is -91.41%, which clearly does not meet this standard.

**Example:** A company with a high ROIC of 25% indicates that it uses its capital more efficiently than one with a lower ROIC like 8%.

Interest Coverage and Financial Safety

Interest coverage ratio shows how easily a company can pay off its interest expenses. StockValueFinder prefers companies with an interest coverage ratio of at least 6, indicating financial stability. Hyperion DeFi, Inc.'s test result did not pass this criterion.

**Example:** A company with an interest coverage ratio of 10 is in better financial health than one with a ratio of 3, as it can more easily cover its debt obligations.

Debt Payback and Balance Sheet Discipline

Debt payback years measure how long it would take for a company to repay all its debts using current earnings. StockValueFinder prefers companies that can repay their debts within three years or less. Hyperion DeFi, Inc.'s debt payback period is -0.53 years, which passes this test.

**Example:** A company with a debt payback period of 2 years is in better financial shape than one with a period of 8 years, as it can repay its debts faster and has lower long-term risk.

P/E Ratio and Valuation Discipline

The Price-to-Earnings (P/E) ratio helps investors assess whether a stock's price reflects fair value relative to earnings. StockValueFinder prefers a P/E ratio below 15 for valuation discipline. Hyperion DeFi, Inc.'s current P/E ratio is -0.28, which passes this test.

**Example:** A company with a P/E of 10 might be considered undervalued compared to one with a P/E of 30, assuming the business quality and growth prospects are similar.

Moving Average Trend and Entry Timing

The moving average signal for Hyperion DeFi, Inc. is WEAK TREND, indicating that the stock price has been declining relative to its short-term averages. The entry signal is N/A, meaning there is no specific timing indicator based on current trends.

**Example:** A strong trend would be indicated by a rising 50-day moving average crossing above a rising 200-day moving average, suggesting continued upward momentum in the stock price.

Overall Financial Strengths and Weaknesses

Hyperion DeFi, Inc.'s financial profile is mixed. The company passes the debt payback test but fails on EPS consistency, ROIC, interest coverage, and trend signals. This suggests that while HYPD may have some short-term liquidity advantages, it struggles with profitability and efficient capital use.

Risks and Limitations

Investing in biotechnology companies like Hyperion DeFi, Inc., involves significant risks due to the high costs of research and development, regulatory hurdles, and uncertain market acceptance. The current financial metrics indicate that HYPD faces challenges in maintaining consistent earnings and managing debt effectively.

Additionally, the WEAK TREND signal suggests that the stock price is not showing positive momentum at this time, which may discourage short-term traders looking for upward movement.

Educational Conclusion

Understanding how to evaluate stocks using financial ratios like EPS, ROIC, P/E ratio, and interest coverage helps investors make informed decisions. Hyperion DeFi, Inc.'s current metrics suggest that it does not meet the criteria set by StockValueFinder for a strong investment at this time due to its poor earnings performance, low capital efficiency, and weak trend signals.

This article is for research and educational purposes only. It is not personal financial advice, investment advice, or a recommendation to buy or sell any security.


Research links: Yahoo Finance | Seeking Alpha | Finviz | SEC Filings

Research Attribution
Max Qwen II

Specializing in monetary economics, market incentives, and investment risk.

30-Day Trendline Analysis

Optional intraday chart with rising support, falling resistance, and multi-timeframe views.

Load detailed price structure only when needed. Downloads roughly 30 days of 5-minute candles, identifies swing points, then calculates validated support and resistance lines.
Scroll to Top